基本健康CAH
紐約證券 · USD
199.38
+1.20
(+0.61%)
盤中 12/15 11:00 (UTC+8)
12/15 11:00 (UTC+8)
基本健康CAH
199.38
+1.20
(+0.61%)
財務數據
損益表
- 534.53
- 547.63
- 575.58
- 550.27
- 598.67
- 522.77
- 552.64
- 548.78
- 601.59
- 640.09
- 5.87
- 2.45
- 5.10
- -4.40
- 8.80
- -12.68
- 5.71
- -0.70
- 9.62
- 6.40
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 64,009,000 | 60,159,000 | 54,878,000 | 55,264,000 | 52,277,000 | 59,867,000 | 55,027,000 | 57,558,000 | 54,763,000 | 53,453,000 |
營業成本 | 61,690,000 | 57,957,000 | 52,755,000 | 53,323,000 | 50,375,000 | 57,985,000 | 53,063,000 | 55,687,000 | 52,995,000 | 51,626,000 |
營業毛利 | 2,319,000 | 2,202,000 | 2,123,000 | 1,941,000 | 1,902,000 | 1,882,000 | 1,964,000 | 1,871,000 | 1,768,000 | 1,827,000 |
營業費用 | 1,651,000 | 1,774,000 | - | - | - | - | - | 1,371,000 | 1,782,000 | 1,690,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 1,461,000 | 1,484,000 | 1,315,000 | 1,306,000 | 1,277,000 | 1,277,000 | 1,308,000 | 1,294,000 | 1,197,000 | 1,267,000 |
非經常性項目費用 | 86,000 | 157,000 | -74,000 | -19,000 | -17,000 | 127,000 | 214,000 | 14,000 | 521,000 | 354,000 |
其他營業費用 | 104,000 | 133,000 | 152,000 | 105,000 | 74,000 | 77,000 | 80,000 | 63,000 | 64,000 | 69,000 |
營業利益 | 668,000 | 428,000 | 730,000 | 549,000 | 568,000 | 401,000 | 362,000 | 500,000 | -14,000 | 137,000 |
其他收入及費用 | 10,000 | 30,000 | 9,000 | -3,000 | 5,000 | -1,000 | 16,000 | 19,000 | 2,000 | -1,000 |
利息費用 | 80,000 | 74,000 | 74,000 | 35,000 | 32,000 | 9,000 | 41,000 | 11,000 | 14,000 | 15,000 |
稅前純益 | 598,000 | 384,000 | 665,000 | 511,000 | 541,000 | 391,000 | 337,000 | 508,000 | -26,000 | 121,000 |
所得稅 | 144,000 | 141,000 | 157,000 | 110,000 | 124,000 | 158,000 | 76,000 | 137,000 | -32,000 | 187,000 |
稅後純益 | 450,000 | 239,000 | 506,000 | 400,000 | 416,000 | 235,000 | 260,000 | 370,000 | 5,000 | -64,000 |
基本每股稅後盈餘(元) | 1.89 | 1.01 | 2.11 | 1.65 | 1.70 | 0.96 | 1.07 | 1.50 | 0.02 | -0.25 |
稀釋每股稅後盈餘(元) | 1.88 | 1.01 | 2.09 | 1.65 | 1.70 | 0.95 | 1.07 | 1.48 | -0.05 | 0.03 |
基本平均股數(千股) | 238000.00 | 239000.00 | 240000.00 | 242000.00 | 243000.00 | 244000.00 | 243000.00 | 245000.00 | 249000.00 | 254000.00 |
稀釋平均股數(千股) | 239000.00 | 240000.00 | 241000.00 | 243000.00 | 245000.00 | 245000.00 | 245000.00 | 246000.00 | 250000.00 | 254000.00 |
還原基本每股稅後盈餘(元) | 1.89 | 1.01 | 2.11 | 1.65 | 1.70 | 0.96 | 1.07 | 1.50 | 0.02 | -0.25 |
還原稀釋每股稅後盈餘(元) | 1.88 | 1.01 | 2.09 | 1.65 | 1.70 | 0.95 | 1.07 | 1.48 | -0.05 | 0.03 |
還原基本平均股數(千股) | 238,000 | 239,000 | 240,000 | 242,000 | 243,000 | 244,000 | 243,000 | 245,000 | 249,000 | 254,000 |
還原稀釋平均股數(千股) | 239,000 | 240,000 | 241,000 | 243,000 | 245,000 | 245,000 | 245,000 | 246,000 | 250,000 | 254,000 |
EBITDA(千元) | 907,000 | 663,000 | 944,000 | 737,000 | 754,000 | 588,000 | 554,000 | 693,000 | 159,000 | 314,000 |